Followers | 777 |
Posts | 81244 |
Boards Moderated | 9 |
Alias Born | 12/25/2009 |
Wednesday, June 22, 2022 12:56:07 PM
The path to full legalization of psychedelics is creating a massive market and enormous opportunity for us to be a salient early entrant in an industry that will help people heal. We have terpene blends, which are not regulated, that we are ready to take to the market internationally. We have approval from a forward-thinking country, South Korea, to conduct our psilocybin research work. The next phase after trials for KRTL Biotech will be to partner with existing and certified mental health clinics, treatment centers with doctors, mental health physicians and professionals who we expect to become our target market for psilocybin and psychotropic substances legally produced by KRTL Biotech to treat their patients once approved and legalized.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM